Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-067054
Filing Date
2020-05-28
Accepted
2020-05-28 16:16:47
Documents
44
Period of Report
2020-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm1927473-1_10k.htm 10-K 613645
2 EXHIBIT 4.2 tm1927473d1_ex4-2.htm EX-4.2 6647
3 EXHIBIT 31.1 tm1927473d1_ex31-1.htm EX-31.1 9285
4 EXHIBIT 31.2 tm1927473d1_ex31-2.htm EX-31.2 9232
5 EXHIBIT 32.1 tm1927473d1_ex32-1.htm EX-32.1 5340
6 EXHIBIT 32.2 tm1927473d1_ex32-2.htm EX-32.2 4967
  Complete submission text file 0001104659-20-067054.txt   2482783

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bzyr-20200229.xml EX-101.INS 369186
8 XBRL TAXONOMY EXTENSION SCHEMA bzyr-20200229.xsd EX-101.SCH 33134
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bzyr-20200229_cal.xml EX-101.CAL 20866
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bzyr-20200229_lab.xml EX-101.LAB 254810
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bzyr-20200229_pre.xml EX-101.PRE 170859
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bzyr-20200229_def.xml EX-101.DEF 87079
Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055
Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

EIN.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0229
Type: 10-K | Act: 34 | File No.: 000-23425 | Film No.: 20921263
SIC: 2835 In Vitro & In Vivo Diagnostic Substances